{"transactions":[{"id":1100382,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":78050,"kind":"person","name":"Collins James J.","position":1,"cik":"0001779269","reported_name":"Collins James J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-27T23:55:15.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":21950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying this option vest upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the 2026 Annual Meeting, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":21950,"derivative":{"exercise_price":2.05,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":21950},"source":{"system":"sec-edgar","filing":"0000950170-25-091158","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000095017025091158/ownership.xml","form_type":"4"}},{"id":1212499,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":78050,"kind":"person","name":"Collins James J.","position":1,"cik":"0001779269","reported_name":"Collins James J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-11T20:20:53.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":43900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying this option vest on the first anniversary of the date of grant, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":43900,"derivative":{"exercise_price":3.52,"expiration_date":"2035-03-06","underlying":"Common Stock","underlying_shares":43900},"source":{"system":"sec-edgar","filing":"0001854270-25-000031","document":"wk-form4_1741724446.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427025000031/wk-form4_1741724446.xml","form_type":"4"}},{"id":1455375,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":78050,"kind":"person","name":"Collins James J.","position":1,"cik":"0001779269","reported_name":"Collins James J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-12T20:16:29.000Z","date":"2024-07-10","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying this option vest upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the 2025 Annual Meeting, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":62500,"derivative":{"exercise_price":0.31,"expiration_date":"2034-07-09","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001854270-24-000085","document":"wk-form4_1720815383.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427024000085/wk-form4_1720815383.xml","form_type":"4"}},{"id":1475446,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":78050,"kind":"person","name":"Collins James J.","position":1,"cik":"0001779269","reported_name":"Collins James J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-18T16:20:06.000Z","date":"2024-06-17","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 17, 2024 and is scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service."}],"balance_after":30000,"derivative":{"exercise_price":7,"expiration_date":"2034-06-16","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950170-24-074883","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779269/000095017024074883/ownership.xml","form_type":"4"}},{"id":1842053,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":78050,"kind":"person","name":"Collins James J.","position":1,"cik":"0001779269","reported_name":"Collins James J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-29T16:16:09.000Z","date":"2023-06-27","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 27, 2023 and is scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service."}],"balance_after":30000,"derivative":{"exercise_price":3.16,"expiration_date":"2033-06-26","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950170-23-030752","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779269/000095017023030752/ownership.xml","form_type":"4"}},{"id":1848000,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":78050,"kind":"person","name":"Collins James J.","position":1,"cik":"0001779269","reported_name":"Collins James J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-21T23:13:48.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying this option vest upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the 2024 Annual Meeting, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":62500,"derivative":{"exercise_price":0.99,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001854270-23-000076","document":"wk-form4_1687389217.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427023000076/wk-form4_1687389217.xml","form_type":"4"}},{"id":1886943,"issuer":{"id":113330,"kind":"organization","name":"Orion Biotech Opportunities Corp.","symbol":"ORIA"},"owners":[{"id":78050,"kind":"person","name":"Collins James J.","position":1,"cik":"0001779269","reported_name":"Collins James J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B ordinary shares","published_at":"2023-05-18T16:05:11.000Z","date":"2023-05-17","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On April 21, 2023, the Issuer announced that it will not consummate an initial business combination within the time period required. Pursuant to the Issuer's Amended and Restated Memorandum and Articles of Association (the \"Articles\") and in connection with the winding up of the Issuer, the Class B ordinary shares, par value $0.0001, held by the Reporting Person were surrendered for no compensation on May 17, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On April 21, 2023, the Issuer announced that it will not consummate an initial business combination within the time period required. Pursuant to the Issuer's Amended and Restated Memorandum and Articles of Association (the \"Articles\") and in connection with the winding up of the Issuer, the Class B ordinary shares, par value $0.0001, held by the Reporting Person were surrendered for no compensation on May 17, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On April 21, 2023, the Issuer announced that it will not consummate an initial business combination within the time period required. Pursuant to the Issuer's Amended and Restated Memorandum and Articles of Association (the \"Articles\") and in connection with the winding up of the Issuer, the Class B ordinary shares, par value $0.0001, held by the Reporting Person were surrendered for no compensation on May 17, 2023."}],"balance_after":0,"derivative":{"underlying":"Class A ordinary shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001213900-23-041168","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779269/000121390023041168/ownership.xml","form_type":"4"}},{"id":2207126,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":78050,"kind":"person","name":"Collins James J.","position":1,"cik":"0001779269","reported_name":"Collins James J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-15T22:00:30.000Z","date":"2022-07-13","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in 36 substantially equal monthly installments over three years from July 13, 2022, subject to the reporting person's continued service through the applicable vesting date. The vested shares subject to such option shall be exercisable upon the effectiveness of the Issuer's registration statement on Form S-8, registering the shares of the Issuer's 2022 Equity Incentive Plan with the U.S. Securities and Exchange Commission."}],"balance_after":125000,"derivative":{"exercise_price":1.75,"expiration_date":"2032-07-12","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000899243-22-026141","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000089924322026141/doc4.xml","form_type":"4"}},{"id":2219407,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":78050,"kind":"person","name":"Collins James J.","position":1,"cik":"0001779269","reported_name":"Collins James J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-29T17:00:18.000Z","date":"2022-06-27","kind":"grant","acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 27, 2022 and is scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service."}],"balance_after":19000,"derivative":{"exercise_price":5.22,"expiration_date":"2032-06-26","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0000899243-22-024522","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779269/000089924322024522/doc4.xml","form_type":"4"}},{"id":2672188,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":78050,"kind":"person","name":"Collins James J.","position":1,"cik":"0001779269","reported_name":"Collins James J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-11T17:11:02.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 9, 2021 and is scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service."}],"balance_after":15000,"derivative":{"exercise_price":8.85,"expiration_date":"2031-06-08","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-21-023288","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779269/000089924321023288/doc4.xml","form_type":"4"}},{"id":3110733,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":78050,"kind":"person","name":"Collins James J.","position":1,"cik":"0001779269","reported_name":"Collins James J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-15T16:15:55.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":9285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 11, 2020 and is scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service."}],"balance_after":9285,"derivative":{"exercise_price":17.63,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":9285},"source":{"system":"sec-edgar","filing":"0000899243-20-016497","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779269/000089924320016497/doc4.xml","form_type":"4"}},{"id":3459244,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":78050,"kind":"person","name":"Collins James J.","position":1,"cik":"0001779269","reported_name":"Collins James J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-07-18T17:28:21.000Z","date":"2019-07-18","kind":"grant","acquired":true,"shares":5714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on July 18, 2019. The shares underlying the option are scheduled to vest on July 18, 2020 or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date."}],"balance_after":5714,"derivative":{"exercise_price":16,"expiration_date":"2029-07-17","underlying":"Common Stock","underlying_shares":5714},"source":{"system":"sec-edgar","filing":"0001104659-19-040972","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779269/000110465919040972/a4.xml","form_type":"4"}}]}